Novartis Gene Therapies Industry Update Webinar “Gene Therapies Redefining Treatment in Neuromuscul Published 2021-08-13 Download video MP4 360p Download video MP4 720p Recommendations 26:03 A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy 50:55 New treatment approach 12:30 Psychiatric Interviews for Teaching: Psychosis 01:32 Follow the Evidence 10:37 Top 4 Inherited Mental Health Disorders: What You Need to Know 53:48 Updates in Limb Girdle Muscular Dystrophy 09:51 Psychiatric Interviews for Teaching: Mania 23:23 Prevent Alzheimer’s, improve Depression, Anxiety, and Brain Fog: The Food's Power | Episode 17 of 18 1:02:13 MDA Virtual Learning: Parenting Challenging Behaviors in Children with Neuromuscular Disease 2:44:05 MDA Virtual Learning: ALS Series Day 1 1:23:14 MDA Virtual Learning: Navigating Adolescence with a Neuromuscular Disease 1:00:15 ALS United GNY 2024 Education & Resource Summit Drug Therapies 11:04 Cluster B (Borderline, Antisocial, Narcissistic, Histrionic) Personality Disorders 17:00 Psychosis & Schizophrenia Mnemonics (Memorable Psychiatry Lecture) 2:02:02 MDA Virtual Learning: ALS Series Day 2 14:06 How To Tell what Mania and Hypomania Really Look like 48:34 The role of AI in clinical trials 17:20 6 Must Know Facts About Borderline Personality Disorder (BPD) 17:39 THIS Is MUCH EASIER Than Fasting With Amazing Results 54:45 MDA Advocacy Institute: ALS Policy Updates Similar videos 14:22 AveXis, A Novartis Company 1:02:27 Plenary Session: The Realities of Bringing Gene Therapies to Market 00:56 👏❤️🙏 20:55 Friedreich's Ataxia Part 5: Research into Gene Therapy 41:57 New Research & Clinical Trials 1:02:45 2021 Virtual SMA Conference: Research and Clinical Care Updates 57:51 Rare Disease Disorders and CNS Drug Development- Paving the Way for Precision Medicine 1:05:42 Avidity Biosciences Dec 2022 - Meet the DM Drug Developers 3:45:05 MDA Engage Pediactric Neuromuscular Seminar 04:09 Friedreich's Ataxia and me 00:50 Join Cromos Pharma at World Orphan Drugs Congress - Europe- 2-5 November 2020 09:31 New Clinical Trial soon for Intellia Therapeutics - FDA accepts IND for NTLA-5001 1:00:37 Rare disease market access webinar: Challenges facing orphan medicines entering Europe 48:43 Stanford Seminar - A Needs-Based Innovation Framework 1:07:59 Let's Talk About Women's Health 1:04:36 Patents v Open Innovation: Incentivising ‘Medicines for the Many’ 1:15:01 Nathan talks about what it's like being a father to a child with Duchenne (Destroy Duchenne Podcast) 1:00:44 [On-Demand Webinar] Rare Disease Clinical Trials: An Opportunity for Differentiated Services 1:01:39 NextGen Precision Health: Where Are We Now? Where Are We Going? (Richard Barohn, MD) More results